S. Meiners (Munich, Germany), L. Donnelly (London, United Kingdom)
A role for the WFDC protein, WAP2, in regulation of innate host defence in the lung
A. Glasgow, D. Small, A. Scott, D. McLean, N. Camper, U. Hamid, S. Hegarty, C. O'Kane, D. McAuley, F. Lundy, S. Elborn, S. Weldon, C. Taggart (Belfast, United Kingdom)
|  |
Smoking alters alpha1-antitrypsin in alveolar macrophages possibly promoting misfolding
S. Baraldo, E. Bazzan, C. Radu, G. Turato, B. Molena, S. Ortolan, R. Cazzuffi, N. Nannini, M. Schiavon, F. Calabrese, F. Rea, P. Simioni, M. Cosio, M. Saetta (Padova, Italy; Montreal, Canada)
| |
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
A. Glasgow, N. Camper, D. Quinn, S. Elborn, S. Weldon, C. Taggart (Belfast, United Kingdom)
| |
Neutrophil elastase-activated host defence peptide prodrugs kill pseudomonas aeruginosa in a cystic fibrosis lung milieu
E. Forde, H. Humphreys, C. Greene, D. Fitzgerald-Hughes, M. Devocelle (Dublin, Ireland)
|  |
Urokinase plasminogen activation receptor (uPAR) levels correlate with bronchial epithelial barrier integrity
M. Slater, D. Shaw, I. Sayers (Nottingham, United Kingdom)
| |
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
E. Papakonstantinou, I. Klagas, G. Karakiulakis, S. Savic Prince, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece)
| |
ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke
F. Polverino, M. Laucho Contreras, M. Divo, V. Pinto-Plata, B. Celli, C. A. Owen (Boston, Albuquerque, United States Of America; Parma, Italy)
| |
Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD
G. John-Schuster, K. Hager, T. Conlon, M. Irmler, J. Beckers, O. Eickelberg, A. O. Yildirim (Neuherberg, München, Germany)
| |